Key result
CTI ablation for atrial flutter may resolve ventricular tachycardia via cross-chamber induction.
Why the study?
Translating data and pathophysiologic theories regarding the association between AF and/or AFL and ventricular arrhythmias into treatment strategies has been elusive.
Highlights the potential implications of cross-chamber induction and the resolution of ventricular tachycardia following cavotricuspid isthmus ablation for atrial flutter.
Answers are grounded in this paper and cite their sources.
May suggest cross-chamber effects in select cases; leaves open whether CTI ablation alters VT outcomes, requiring prospective data.
For decades, atrial fibrillation (AF) and/or atrial flutter (AFL) have been described to have positive associations with sudden death and/or ventricular arrhythmias.1 The pathophysiologic basis may be related to electrophysiologic changes that heighten the probability for ventricular tachycardia (VT) and ventricular fibrillation (VF).2 They may also be reflective of advanced heart disease, noncardiac comorbid illnesses, or proarrhythmic adverse consequences of antiarrhythmic drugs. Translating these data and theories into treatment strategies has been elusive.
No takes yet. Share an insight, caveat, or question.
Norman C. Wang (2022) conducted an editorial in Atrial flutter and ventricular tachycardia. Cavotricuspid isthmus ablation was evaluated. Cavotricuspid isthmus ablation for atrial flutter may lead to the resolution of ventricular tachycardia, highlighting the potential implications of cross-chamber induction on ablation strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: